The research & development by business enterprise, pharmaceutical industry in local currency in the Netherlands is now 323.00 million, marking a 10.00 million (3.2%) increase compared to 2020.
Research & development by business enterprise, pharmaceutical industry in local currency in the Netherlands
No matching regions
Similar regions to the Netherlands
Business R&D pharmaceutical in local currency
More indicators for the Netherlands
Government R&D in security as % of government support
2.6%
+1%
(2021)
Higher-education-finacing R&D financed by general university in local currency
14,230.55M
-517.31M
(1998)
R&D financed by rest of the world in local currency
20,403.43M
+1,253.43M
(2021)
Government R&D financed by rest of the world in local currency
1,114.90M
-165.10M
(2021)
Business R&D financed by rest of the world in local currency
14,598.52M
+1,358.52M
(2021)
Non-profit R&D growth rate
-15.42%
-18.68%
(2002)
Netherlands Business R&D pharmaceutical in local currency between 2013 and 2021
| Period | Business R&D pharmaceutical in local currency | Change |
|---|---|---|
| 2021 | 323.00M | +10.00M |
| 2020 | 313.00M | +49.00M |
| 2019 | 264.00M | +8.00M |
| 2018 | 256.00M | -28.00M |
| 2017 | 284.00M | +31.00M |
| 2016 | 253.00M | -16.00M |
| 2015 | 269.00M | +4.00M |
| 2014 | 265.00M | -23.00M |
| 2013 | 288.00M |